Ran Fuhrer

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

A.D.O. Group Ltd. is a holding company, which engages in the provision of investment services. It operates through the Yielding Residential Real Estate and Condo Apartments for Sale segments. The Yielding Residential Real Estate segment is involved in the management, rental, development, and maintenance of residential and commercial properties. The Condo Apartments for Sale segment includes all aspects related to the preparation and execution of the sale of condo apartments, which includes the conversion of the apartments into separate condo apartments for sale, its maintenance, and temporary rental of apartments until the sale. The company was founded on January 30, 1987 and is headquartered in Ramat Gan, Israel.

Israel Bar Association is a private company headquartered in Tel Aviv, Israel. The firm provides legal services.

Neopharm Ltd. is a pharmaceutical and biotechnology company based in Petach Tikva, Israel. and has subsidiaries in Israel. Neopharm Ltd. engages in research and development of pharmaceutical and biotechnology products. The Israeli company was founded in 1941 by Leopold Goldschmidt. David Fuhrer has been the CEO of the private company since 1980.